Global Digital Respiratory Devices Market - 1-3 USERS:2021

Market Report Coverage :
Start Year : 2021 - Forecast Year : 2030 - Start Value : $46.1 Million in 2021 - Forecast Value : $405.1 Million by 2030 - CAGR % : 0.27%
Description :
Market Report Coverage - Digital Respiratory DevicesMarket Segmentation• By Product (Sensors and Apps, and Smart Inhalers and Nebulizers)• By Indication (Asthma and Chronic Obstructive Pulmonary Disease)Regional Segmentation• North America – U.S., and Canada• Europe – Germany, U.K., France, Rest-of-Europe• Asia-Pacific – China, Japan, India, Australia, and Rest-of-Asia-Pacific• Rest-of-the-WorldGrowth Drivers• Increasing prevalence of respiratory diseases• Increasing adoption of digital technology among individuals• Treatment satisfaction with inhaled therapy among individualsMarket Restraints• Issues related to the accuracy and reliability of the device• Availability and high cost associated with digital respiratory devicesMarket Opportunities• Expansion into the emerging markets• Predicting future exacerbationsKey Companies Profiled3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AstraZeneca, Boehringer Ingelheim International GmbH, Capsule Technologies, Cognita Labs, Cohero Health, Findair Sp. z. o. o, GlaxoSmithKline plc, Novartis AG, Pneuma Respiratory, Propeller Health, Sensiron AG, and Teva Pharmaceuticals Industries Ltd.Key Questions Answered in this Report:• How pharmaceutical companies are capitalizing on the opportunity for connected inhalers to improve drug sales?• What has been the impact of the COVID-19 pandemic on global digital respiratory devices market?• What are the potential recovery scenarios of the market from the COVID-19 pandemic, and how can it impact the market forecast?• How will the pharma industry evolve in terms of drug-based devices in the future?• What are the potential business models in global digital respiratory devices market?• What are the major market drivers, challenges, and opportunities in the global digital respiratory devices market?• What are the underlying structures resulting in the emerging trends within the digital respiratory devices industry?• What was the market value of the leading segments and sub-segments of the global digital respiratory devices market in 2021?• How is each segment of the global digital respiratory devices market expected to grow during the forecast period and what is the revenue anticipated to be generated by each of the segments by the end of 2030?• What are the influencing factors that may affect the market share of the key players?• What is the market share of each of the companies in the global digital respiratory devices market and what are their contributions?Key USPs of the ReportFollowing are some of the key contents of the report:• Porter's five forces analysisThis section includes exhaustive information on the competitive intensity of the market which helps any firm to understand the market, the competitors entering or leaving the market, and the firm’s competitive strategy to operate in the market. • Business Model AnalysisThis section comprises information on the key business models deployed in the market by leading players.• Impact of COVID-19This section of the report encompasses the following:o Impact on digital respiratory devices Demand and Supply o Future Impact (Short-, mid-, and long-term)o Entry Barrier and Opportunities for New EntrantsIn addition, the report provides:• A detailed analysis and growth forecast (2021-2030) for different indications• Recent developments and trends in the global market landscape• Factors promoting and inhibiting the market growthExpert Quote“Lack of consumer awareness is a key barrier to market entry for new players. Digital awareness among consumers is in the process of growth. However, more awareness needs to be created for the same. The lack of an established consumer base can hamper a start-up’s ability to enter the market due to low confidence on business viability and returns.”Scope of the Global Digital Respiratory Devices MarketThe purpose of the study is to enable the reader to gain a holistic view of the Global Digital Respiratory Devices Market by each of the aforementioned segments. The report constitutes an in-depth analysis of the global digital respiratory devices market, including a thorough analysis of the different end-users. The study also provides exhaustive information on competitive landscape, brand share landscape, market share of the leading players, as well as other vital information with respect to the global digital respiratory devices market. The report considers sensors and apps, and smart inhalers and nebulizers. Key Companies in the Global Digital Respiratory Devices MarketSome of the key players contributing to the Global Digital Respiratory Devices Market include 3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AstraZeneca, Boehringer Ingelheim International GmbH, Capsule Technologies, Cognita Labs, Cohero Health, Findair Sp. z. o. o, GlaxoSmithKline plc, Novartis AG, Pneuma Respiratory, Propeller Health, Sensiron AG, and Teva Pharmaceuticals Industries Ltd.
Countries Covered :
North America U.S. CanadaEurope Germany France U.K. Rest-of-EuropeAsia-Pacific China India Australia Japan Rest-of-Asia-PacificRest-of-World
Keywords :
Digital Respiratory Devices, Respiratory Devices, Smart Inhalers and Nebulizers, Smart Inhalers, Smart Nebulizers, Digital Respiratory Devices Market, Digital Respiratory Devices Report, Digital Respiratory Devices Industry, Digital Respiratory Devices Market Forecast, Digital Respiratory Devices Trends, Digital Respiratory Devices Products, Digital Respiratory Devices Applications, Digital Respiratory Devices Technology, Digital Respiratory Devices Companies, Digital Respiratory Devices Market Analysis, Digital Respiratory Devices Industry Analysis, What is Digital Respiratory Devices Market, What are Digital Respiratory Devices Market, Digital Respiratory Devices Market by Product Type, Digital Respiratory Devices Market by Indication, Digital Respiratory Devices Market by Region, North America Digital Respiratory Devices Market, Europe Digital Respiratory Devices Market, Asia-Pacific Digital Respiratory Devices Market
Press Release :
The Global Digital Respiratory Devices Market is projected to reach $405.1 million by 2030, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 27.31% between 2021 and 2030.The comprehensive study of the global digital respiratory devices market by BIS Research extensively covers the following:• Market numbers on product types• More than 35 key products present in the market• Market share analysis for the global digital respiratory devices Market and its indications.• Detailed global and regional market share analysisBesides these parameters, the study also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, end-user analysis, and COVID-19 impact on the market.BIS Research study indicates that increasing prevalence of respiratory diseases, increasing adoption of digital technology among individuals, and treatment satisfaction with inhaled therapy among individuals are fueling the growth of the market. The study highlights the various emerging opportunities, such as expansion into the emerging markets and predicting future exacerbations, which can be leveraged by players operating in the market.Additionally, the market intelligence report by BIS Research throws a spotlight on the porter's five forces analysis, business model analysis, COVID-19 impact and market analysis by product type and indication for the global digital respiratory devices market.To gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include products, indications, and regions. Each of these segments is further categorized into sub-segments and micro-segments to compile an in-depth study. The product segment of the global market includes analysis of different types of products such as sensors and apps, and smart inhalers and nebulizers.The indication segment of the global market includes analysis of different types of indications such as asthma and chronic obstructive pulmonary disease.To emphasize the impact of COVID-19 on the global digital respiratory devices market, Swati Sood, Lead Analyst, BIS Research, states, "The digital respiratory devices market has witnessed a spike in synergistic activities during the COVID-19 pandemic. The accelerated growth rate in adoption is expected to be witnessed during 2021 as well. However, post-2021, growth rates are expected to normalize again. The COVID-19 pandemic is expected to give rise to a new start-up ecosystem in the field of digital respiratory devices. Thus, the major transformation that COVID-19 has brought about to digital respiratory devices in in terms of accelerated adoption rates.”Key insights are drawn from in-depth interviews with the key opinion leaders of leading companies, market participants, and vendors. The key players profiled in the report include 3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AstraZeneca, Boehringer Ingelheim International GmbH, Capsule Technologies, Cognita Labs, Cohero Health, Findair Sp. z. o. o, GlaxoSmithKline plc, Novartis AG, Pneuma Respiratory, Propeller Health, Sensiron AG, and Teva Pharmaceuticals Industries Ltd.The study also offers strategic recommendations that can help organizations in tracking various key trends, and technologies that are changing the dynamics of the market.Who should buy this report?• Manufacturers of digital respiratory devices including smart inhalers and nebulizers• Providers of sensor-based technology which can be integrated with inhalers to form an integrated solution• Developers of apps which can aid in integration, tracking, and connectivity• Start-ups looking to venture into the field of digital and connected respiratory devices• Manufacturers of conventional respiratory devices looking to venture into the field of digital respiratory devicesHow can market intelligence on digital respiratory device add value to an organization’s decision-making process?• Aid in product development • Aid in understanding the key developments of the market• Help in targeting a segment for launching a new product • Support in diversifying the product portfolio for digital respiratory solutions• Aid in understanding market potential of different digital respiratory devices• Aid in understanding digital respiratory devices penetration in different indications• Support in analyzing the market opportunities• Insights on the key companies in the marketInsightful Questions Covered to Enable Companies to take Strategic Decisions• How pharmaceutical companies are capitalizing on the opportunity for connected inhalers to improve drug sales?• What has been the impact of the COVID-19 pandemic on global digital respiratory devices market?• What are the potential recovery scenarios of the market from the COVID-19 pandemic, and how can it impact the market forecast?• How will the pharma industry evolve in terms of drug-based devices in the future?• What are the potential business models in global digital respiratory devices market?• What are the major market drivers, challenges, and opportunities in the global digital respiratory devices market?• What are the underlying structures resulting in the emerging trends within the digital respiratory devices industry?• What was the market value of the leading segments and sub-segments of the global digital respiratory devices market in 2021?• How is each segment of the global digital respiratory devices market expected to grow during the forecast period and what is the revenue anticipated to be generated by each of the segments by the end of 2030?• What are the influencing factors that may affect the market share of the key players?• What is the market share of each of the companies in the global digital respiratory devices market and what are their contributions?
Companies Mentioned :
3M Health Care LimitedAdherium LimitedAmiko Digital Health LimitedAstraZeneca plcBoehringer Ingelheim International GmbHCapsule Technologies, Inc.Cognita LabsCohero HealthFindair Sp. z. o. oGlaxoSmithKline plcNovartis AGPneuma Respiratory, Inc.Propeller HealthSensirion AGTeva Pharmaceuticals Industries Ltd.
Press Release :
The Global Digital Respiratory Devices Market is projected to reach $405.1 million by 2030, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 27.31% between 2021 and 2030.The comprehensive study of the global digital respiratory devices market by BIS Research extensively covers the following:• Market numbers on product types• More than 35 key products present in the market• Market share analysis for the global digital respiratory devices Market and its indications.• Detailed global and regional market share analysisBesides these parameters, the study also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, end-user analysis, and COVID-19 impact on the market.BIS Research study indicates that increasing prevalence of respiratory diseases, increasing adoption of digital technology among individuals, and treatment satisfaction with inhaled therapy among individuals are fueling the growth of the market. The study highlights the various emerging opportunities, such as expansion into the emerging markets and predicting future exacerbations, which can be leveraged by players operating in the market.Additionally, the market intelligence report by BIS Research throws a spotlight on the porter's five forces analysis, business model analysis, COVID-19 impact and market analysis by product type and indication for the global digital respiratory devices market.To gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include products, indications, and regions. Each of these segments is further categorized into sub-segments and micro-segments to compile an in-depth study. The product segment of the global market includes analysis of different types of products such as sensors and apps, and smart inhalers and nebulizers.The indication segment of the global market includes analysis of different types of indications such as asthma and chronic obstructive pulmonary disease.To emphasize the impact of COVID-19 on the global digital respiratory devices market, Swati Sood, Lead Analyst, BIS Research, states, "The digital respiratory devices market has witnessed a spike in synergistic activities during the COVID-19 pandemic. The accelerated growth rate in adoption is expected to be witnessed during 2021 as well. However, post-2021, growth rates are expected to normalize again. The COVID-19 pandemic is expected to give rise to a new start-up ecosystem in the field of digital respiratory devices. Thus, the major transformation that COVID-19 has brought about to digital respiratory devices in in terms of accelerated adoption rates.”Key insights are drawn from in-depth interviews with the key opinion leaders of leading companies, market participants, and vendors. The key players profiled in the report include 3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AstraZeneca, Boehringer Ingelheim International GmbH, Capsule Technologies, Cognita Labs, Cohero Health, Findair Sp. z. o. o, GlaxoSmithKline plc, Novartis AG, Pneuma Respiratory, Propeller Health, Sensiron AG, and Teva Pharmaceuticals Industries Ltd.The study also offers strategic recommendations that can help organizations in tracking various key trends, and technologies that are changing the dynamics of the market.Who should buy this report?• Manufacturers of digital respiratory devices including smart inhalers and nebulizers• Providers of sensor-based technology which can be integrated with inhalers to form an integrated solution• Developers of apps which can aid in integration, tracking, and connectivity• Start-ups looking to venture into the field of digital and connected respiratory devices• Manufacturers of conventional respiratory devices looking to venture into the field of digital respiratory devicesHow can market intelligence on digital respiratory device add value to an organization’s decision-making process?• Aid in product development • Aid in understanding the key developments of the market• Help in targeting a segment for launching a new product • Support in diversifying the product portfolio for digital respiratory solutions• Aid in understanding market potential of different digital respiratory devices• Aid in understanding digital respiratory devices penetration in different indications• Support in analyzing the market opportunities• Insights on the key companies in the marketInsightful Questions Covered to Enable Companies to take Strategic Decisions• How pharmaceutical companies are capitalizing on the opportunity for connected inhalers to improve drug sales?• What has been the impact of the COVID-19 pandemic on global digital respiratory devices market?• What are the potential recovery scenarios of the market from the COVID-19 pandemic, and how can it impact the market forecast?• How will the pharma industry evolve in terms of drug-based devices in the future?• What are the potential business models in global digital respiratory devices market?• What are the major market drivers, challenges, and opportunities in the global digital respiratory devices market?• What are the underlying structures resulting in the emerging trends within the digital respiratory devices industry?• What was the market value of the leading segments and sub-segments of the global digital respiratory devices market in 2021?• How is each segment of the global digital respiratory devices market expected to grow during the forecast period and what is the revenue anticipated to be generated by each of the segments by the end of 2030?• What are the influencing factors that may affect the market share of the key players?• What is the market share of each of the companies in the global digital respiratory devices market and what are their contributions?
Headline :
Global Digital Respiratory Devices Market to Reach $405.1 Million by 2030
Table of Contents :
1 Market Overview1.1 Introduction1.2 Digital Respiratory Devices Market Ecosystem1.3 Assumptions and Limitations2 Market Dynamics2.1 Impact Analysis2.2 Market Drivers2.2.1 Increasing Prevalence of Respiratory Diseases2.2.2 Increasing Adoption of Digital Technology Among Individuals2.2.3 Treatment Satisfaction with Inhaled Therapy Among Individuals2.3 Market Restraints2.3.1 Issues Related to The Accuracy and Reliability of the Device2.3.2 Availability and High Cost Associated with Digital Respiratory Devices2.4 Market Opportunities2.4.1 Expansion into the Emerging Markets2.4.2 Predicting Future Exacerbations3 Analysis of COVID-19 Impact on Global Digital Respiratory Devices Market3.1 Impact on Market Size3.1.1 Scenario Comparative Analysis (Pre-COVID-19, During-COVID-19, Post-COVID-19)3.1.2 Regional Impact3.1.2.1 North America3.1.2.2 Europe3.1.2.3 Asia-Pacific3.2 Impact on Digital Respiratory Devices Adoption3.2.1 Short-Term Impact (2-4 Years)3.2.2 Mid-Term Impact (5-8 Years)3.2.3 Long-Term Impact (9-12 Years)3.3 Entry Barrier and Opportunities for New Entrants4 Competitive Landscape4.1 Key Developments and Strategies4.1.1 Agreements and Collaborations4.1.2 Regulatory and Legal Activities4.1.3 Investments, Funding, and Business Expansion4.1.4 Mergers and Acquisitions4.1.5 Awards and Recognitions4.1.6 Product Launches4.2 Market Share Analysis4.3 Industry Attractiveness4.3.1 Bargaining Power of Suppliers4.3.2 Bargaining Power of Buyer4.3.3 Threat of New Entrants4.3.4 Threat of Substitute Products4.3.5 Intensity of Competitive Rivalry5 Industry Insights5.1 Opportunity Map Analysis of Smart Inhalers and Nebulizers5.2 Smart Inhaler Value Propositions for Stakeholders5.3 Smart Inhalers and Nebulizers – An Important Element of System for Predicting Disease Worsening in Individuals5.4 Business Models for Digital Respiratory Devices Market6 Global Digital Respiratory Devices Market (by Product Type)6.1 Sensors and Apps6.2 Smart Inhalers and Nebulizers7 Global Digital Respiratory Devices Market (by Indication)7.1 Asthma7.2 Chronic Obstructive Pulmonary Disease (COPD)8 Global Digital Respiratory Devices Market (by Region)8.1 North America8.1.1 U.S.8.1.2 Canada8.2 Europe8.2.1 Germany8.2.2 U.K.8.2.3 France8.2.4 Rest-of-Europe8.3 Asia-Pacific (APAC)8.3.1 Japan8.3.2 China8.3.3 Australia8.3.4 India8.3.5 Rest-of-Asia-Pacific (RoAPAC)8.4 Rest-of-the-World (RoW)9 Company Profiles9.1 3M Health Care Limited9.1.1 Company Overview9.1.2 Role of 3M Health Care Limited in the Global Digital Respiratory Devices Market9.1.3 Financials9.1.3.1 Key Insights on the Financial Health of the Company9.1.4 SWOT Analysis9.2 Adherium Limited9.2.1 Company Overview9.2.2 Role of Adherium Limited in the Global Digital Respiratory Devices Market.9.2.3 Financials9.2.3.1 Key Insights on the Financial Health of the Company9.2.4 SWOT Analysis9.3 Amiko Digital Health Limited9.3.1 Company Overview9.3.2 Role of Amiko Digital Health Limited in the Global Digital Respiratory Devices Market9.3.3 SWOT Analysis9.4 AstraZeneca plc9.4.1 Company Overview9.4.2 Role of AstraZeneca plc in the Global Digital Respiratory Devices Market9.4.3 Financials9.4.3.1 Key Insights on the Financial Health of the Company9.4.4 SWOT Analysis9.5 Boehringer Ingelheim International GmbH9.5.1 Company overview9.5.2 Role of Boehringer Ingelheim International GmbH in the Global Digital Respiratory Devices Market9.5.3 Financials9.5.3.1 Key Insights on the Financial Health of the Company9.5.4 SWOT Analysis9.6 Capsule Technologies, Inc.9.6.1 Company Overview9.6.2 Role of Capsule Technologies, Inc. in the Global Digital Respiratory Devices Market.9.6.3 SWOT Analysis9.7 Cognita Labs9.7.1 Company Overview9.7.2 Role of Cognita Labs in the Global Digital Respiratory Devices Market9.7.3 SWOT Analysis9.8 Cohero Health9.8.1 Company Overview9.8.2 Role of Cohero Health in the Global Digital Respiratory Devices Market9.8.3 SWOT Analysis9.9 Findair Sp. z. o. o9.9.1 Company Overview9.9.2 Role of Findair Sp. z. o. o in the Global Digital Respiratory Devices Market9.9.3 SWOT Analysis9.1 GlaxoSmithKline plc9.10.1 Company overview9.10.2 Role of GlaxoSmithKline plc in the Global Digital Respiratory Devices Market9.10.3 Financials9.10.3.1 Key Insights on the Financial Health of the Company9.10.4 SWOT Analysis9.11 Novartis AG9.11.1 Company overview9.11.2 Role of Novartis AG in the Global Digital Respiratory Devices Market9.11.3 Financials9.11.3.1 Key Insights on the Financial Health of the Company9.11.4 SWOT Analysis9.12 Pneuma Respiratory, Inc.9.12.1 Company Overview9.12.2 Role of Pneuma Respiratory, Inc. in the Global Digital Respiratory Devices Market9.12.3 SWOT Analysis9.13 Propeller Health9.13.1 Company Overview9.13.2 Role of Propeller Health in the Global Digital Respiratory Devices Market9.13.3 SWOT Analysis9.14 Sensirion AG9.14.1 Company overview9.14.2 Role of Sensirion AG in the Global Digital Respiratory Devices Market9.14.3 Financials9.14.3.1 Key Insights on the Financial Health of the Company9.14.4 SWOT Analysis9.15 Teva Pharmaceuticals Industries Ltd.9.15.1 Company Overview9.15.2 Role of Teva Pharmaceuticals Industries Ltd. in the Global Digital Respiratory Devices Market9.15.3 Financials9.15.3.1 Key Insights on the Financial Health of the Company9.15.4 SWOT Analysis10 Research Scope and Methodology10.1 Product Definition10.2 Scope of the Research StudyList of Tables Table 1: Research and Facilitation FrameworkTable 2: Global Digital Respiratory Devices Market Dynamic Impact AnalysisTable 2.1: Impact Analysis of Global Digital Respiratory Devices MarketTable 2.2: Incidence of Asthma in Key Countries, 2017-2019Table 2.3: Incidence of COPD in Key Countries, 2017-2019Table 3.1: Global Digital Respiratory Devices Market: Barriers to EntryTable 5.1: Smart Inhaler Value Propositions for StakeholdersTable 5.2: Different Data Revenue StreamsTable 6.1: Global Digital Respiratory Devices Market: Smart Inhalers in PipelineTable 7.1: Incidence of Asthma in Key Countries, 2017-2019Table 7.2: Incidence of COPD in Key Countries, 2017-2019List of Figures Figure 1: Opportunities for Clinical BenefitFigure 2: Global Digital Respiratory Devices Market, 2018-2030Figure 3: Global Digital Respiratory Devices Market: Dominating Segment, 2019 and 2030Figure 4: Global Digital Respiratory Devices Market (by Product Type), 2019 and 2030Figure 5: Global Digital Respiratory Devices Market (by Indication), 2019 and 2030Figure 6: Global Digital Respiratory Devices Market (by Region), 2019 and 2030Figure 7: Global Digital Respiratory Devices: Strategies Incorporated to Expand Global ReachFigure 8: Go-To-Market StrategyFigure 1.1: Digital Respiratory Devices Market WorkflowFigure 1.2: Smart Inhalers and Data FlowFigure 1.3: Digital Respiratory Devices Market EcosystemFigure 3.1: Global Digital Respiratory Devices Market: Scenario Comparative AnalysisFigure 3.2: COVID-19 Trend (Daily Cases), December 31, 2019-December 14, 2020Figure 3.3: Global Digital Respiratory Devices Market COVID-19 Impact (by Key Regions), 2019-2030Figure 3.4: Potential COVID-19 Recovery ScenariosFigure 3.5: Global Prevalence (Asthma and COPD) Historical and Forecast Growth Rates, 1990-2032Figure 3.6: Global Digital Respiratory Diseases Market: Opportunities for New PlayersFigure 4.1: Competitive Landscape, January 2015-March 2021Figure 4.2: Share of Key Developments and Strategies, January 2015-March 2021Figure 4.3: Agreements and Collaborations Share (by Company), January 2015 - March 2021Figure 4.4: Regulatory and Legal Activities Share (by Company), January 2015- March 2021Figure 4.5: Investments, Funding, and Business Expansions Share (by Company), January 2015-March 2021Figure 4.6: Mergers and Acquisitions Share (by Company), January 2015- March 2021Figure 4.7: Awards and Recognitions Share (by Company), January 2015-March 2021Figure 4.8: Product Launches Share (by Companies), January 2015-March 2021Figure 4.9: Global Digital Respiratory Devices Market Share Analysis, 2018 and 2019Figure 4.10: Porter’s Five Forces AnalysisFigure 4.11: Bargaining Power of Suppliers: Overall Impact, 2018-2030Figure 4.12: Bargaining Power of Buyers: Overall Impact, 2018-2030Figure 4.13: Threat of New Entrant: Overall Impact, 2018-2030Figure 4.14: Threat of Substitute Products: Overall Impact, 2018-2030Figure 4.15: Intensity of Competitive Rivalry: Overall Impact, 2018-2030Figure 5.1: Global Digital Respiratory Devices Market: Opportunity Map AnalysisFigure 5.2: Smart Inhalers and Nebulizers – An Important Element of System for Predicting Disease Worsening in IndividualsFigure 6.1: Global Digital Respiratory Devices Market (by Product Type)Figure 6.2: Global Digital Respiratory Devices Market Share (by Product Type), 2019 and 2030Figure 6.3: Global Digital Respiratory Devices Market (Sensors and Apps), $Million, 2018-2030Figure 6.4: Global Digital Respiratory Devices Market (Smart Inhalers and Nebulizers), $Million, 2018-2030Figure 7.1: Global Digital Respiratory Devices Market (by Indication)Figure 7.2: Global Digital Respiratory Devices Market Share (by Indication), 2019 and 2030Figure 7.3: Global Digital Respiratory Devices Market (Asthma), $Million, 2018-2030Figure 7.4: Global Digital Respiratory Devices Market (COPD), $Million, 2018-2030Figure 8.1: Global Digital Respiratory Devices Market (by Region)Figure 8.2: Global Digital Respiratory Devices Market (by Region), $Million, 2018-2030Figure 8.3: North America Digital Respiratory Devices Market, $Million, 2018-2030Figure 8.4: North America Digital Respiratory Devices Market (by Country), $Million, 2018-2030Figure 8.5: U.S. Digital Respiratory Devices Market, $Million, 2018-2030Figure 8.6: Canada Digital Respiratory Devices Market, $Million, 2018-2030Figure 8.7: Europe Digital Respiratory Devices Market, $Million, 2018-2030Figure 8.8: Europe Digital Respiratory Devices Market (by Country), $Million, 2018-2030Figure 8.9: Germany Digital Respiratory Devices Market, $Million, 2018-2030Figure 8.10: U.K. Digital Respiratory Devices Market, $Million, 2018-2030Figure 8.11: France Digital Respiratory Devices Market, $Million, 2018-2030Figure 8.12: Rest-of-Europe Digital Respiratory Devices Market, $Million, 2018-2030Figure 8.13: Asia-Pacific Digital Respiratory Devices Market, $Million, 2018-2030Figure 8.14: Asia-Pacific Digital Respiratory Devices Market (by Country), 2018-2030Figure 8.15: Japan Digital Respiratory Devices Market, $Million, 2018-2030Figure 8.16: China Digital Respiratory Devices Market, $Million, 2018-2030Figure 8.17: Australia Digital Respiratory Devices Market, $Million, 2018-2030Figure 8.18: India Digital Respiratory Devices Market, $Million, 2018-2030Figure 8.19: Rest-of-Asia-Pacific Digital Respiratory Devices Market, $Million, 2018-2030Figure 8.20: Rest-of-the-World Digital Respiratory Devices Market, $Million, 2018-2030Figure 9.1: Shares of Company ProfilesFigure 9.2: 3M Health Care Limited: Overall Product PortfolioFigure 9.3: 3M Health Care Limited: Overall Financials, 2018-2020Figure 9.4: 3M Health Care Limited: Revenue (by Business Segment), 2018-2020Figure 9.5: 3M Health Care Limited: Revenue (by Region), 2018-2020Figure 9.6: 3M Health Care Limited: R& D Expense, 2018-2020Figure 9.7: 3M Health Care Limited: SWOT AnalysisFigure 9.8: Adherium Limited: Overall Product PortfolioFigure 9.9: Adherium Limited: Overall Financials, 2018-2020Figure 9.10: Adherium Limited: R& D Expense, 2018-2020Figure 9.11: Adherium Limited: SWOT AnalysisFigure 9.12: Amiko Digital Health Limited: Overall Product PortfolioFigure 9.13: Amiko Digital Health Limited: SWOT AnalysisFigure 9.14: AstraZeneca plc: Overall Product PortfolioFigure 9.15: AstraZeneca plc: Overall Financials, 2018-2020Figure 9.16: AstraZeneca plc: Net Revenue (by Region), 2018-2020Figure 9.17: AstraZeneca plc: R& D Expense, 2018-2020Figure 9.18: AstraZeneca plc: SWOT AnalysisFigure 9.19: Boehringer Ingelheim International GmbH: Product OfferingsFigure 9.20: Boehringer Ingelheim International GmbH: Overall Financials, 2017-2019Figure 9.21: Boehringer Ingelheim International GmbH Net Revenue (by Business Segment), 2017-2019Figure 9.22: Boehringer Ingelheim International GmbH: Net Revenue (by Region), 2017-2019Figure 9.23: Boehringer Ingelheim International GmbH: R& D Expense, 2017-2019Figure 9.24: AstraZeneca plc: SWOT AnalysisFigure 9.25: Capsule Technologies, Inc.: SWOT AnalysisFigure 9.26: Cognita Labs: Overall Product PortfolioFigure 9.27: Cohero Health: SWOT AnalysisFigure 9.28: Cohero Health: Overall Product PortfolioFigure 9.29: Cohero Health: SWOT AnalysisFigure 9.30: Findair Sp. z. o. o: Overall Product PortfolioFigure 9.31: Findair Sp. z. o. o: SWOT AnalysisFigure 9.32: GlaxoSmithKline plc: Product OfferingsFigure 9.33: GlaxoSmithKline plc: Overall Financials, 2018-2020Figure 9.34: GlaxoSmithKline plc Net Revenue (by Business Segment), 2018-2020Figure 9.35: GlaxoSmithKline plc: Net Revenue (by Region), 2018-2020Figure 9.36: GlaxoSmithKline plc: R& D Expense, 2018-2020Figure 9.37: GlaxoSmithKline plc: SWOT AnalysisFigure 9.38: Novartis AG: Product OfferingsFigure 9.39: Novartis AG: Overall Financials, 2018-2020Figure 9.40: Novartis AG: Net Revenue (by Business Segment), 2018-2020Figure 9.41: Novartis AG: Net Revenue (by Region), 2018-2020Figure 9.42: Novartis AG: R&D Expense, 2018-2020Figure 9.43: Novartis AG: SWOT AnalysisFigure 9.44: Pneuma Respiratory, Inc.: Overall Product PortfolioFigure 9.45: Pneuma Respiratory, Inc.: SWOT AnalysisFigure 9.46: Propeller Health: Product Offerings for Digital Respiratory Devices MarketFigure 9.47: Propeller Health: SWOT AnalysisFigure 9.48: Sensirion AG: Overall Product PortfolioFigure 9.49: Sensirion AG: Overall Financials, 2017-2019Figure 9.50: Sensirion AG: Net Revenue (by Business Segment), 2017-2019Figure 9.51: Sensirion AG: Net Revenue (by Region), 2017-2019Figure 9.52: Sensirion AG: R&D Expense, 2017-2019Figure 9.53: Sensirion AG: SWOT AnalysisFigure 9.54: Product Offerings for Global Digital Respiratory Devices MarketFigure 9.55: Teva Pharmaceuticals Industries Ltd.: Net Revenue (by Business Segment), 2017-2019Figure 9.56: Teva Pharmaceuticals Industries Ltd.: Net Revenue (by Region), 2017-2019Figure 9.57: Teva Pharmaceuticals Industries Ltd.: R& D Expense, 2017-2019Figure 9.58: Teva Pharmaceuticals Industries Ltd.: SWOT AnalysisFigure 10.1: Global Digital Respiratory Devices Market SegmentationFigure 10.2: Research MethodologyFigure 10.3: Primary ResearchFigure 10.4: Secondary ResearchFigure 10.5: Data TriangulationFigure 10.6: Bottom-up Approach (Segment-wise Analysis)Figure 10.7: Top-down Approach (Segment-wise Analysis)Figure 10.8: Assumptions and LimitationsFigure 10.9: Considered Factors for Data Prediction and Modelling